Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:approvalYear |
2014
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01XX45
|
| gptkbp:CASNumber |
414864-00-9
|
| gptkbp:developer |
gptkb:Spectrum_Pharmaceuticals
|
| gptkbp:genericName |
gptkb:belinostat
|
| https://www.w3.org/2000/01/rdf-schema#label |
Beleodaq
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
histone deacetylase inhibitor
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:PubChem_CID |
6918637
7972082 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:anemia
nausea vomiting fatigue thrombocytopenia dyspnea |
| gptkbp:UNII |
KXJ3Q0GC8M
|
| gptkbp:usedFor |
treatment of peripheral T-cell lymphoma
|
| gptkbp:bfsParent |
gptkb:Spectrum_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|